MarketCapExport financials
Science Applications International Corporation (SAIC)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Science Applications International Corporation SAIC
$ 152.7
0.16%
Facebook
X
Telegram
Science Applications International Corporation Financial Ratios 2026-2011 | SAIC
Brief overview of Science Applications International Corporation's financial ratios
Current figures are compared with the company's own five-year history for 2022–2026.
Key multiples at the end of the period are P/E 12.03x (median 15.92x), EV/EBITDA 7.49x (median 9.78x), P/S 0.59x (median 0.8x). The combined multiple level is about 25.9% below the company's historical norm, suggesting more cautious expectations.
Current earnings relative to valuation equal about 8.3% on the 1/P/E measure. This is a valuation reference, not an expected payout.
Returns on assets and capital are represented by ROE 23.9%, ROA 6.7%, ROCE 34.7%. Business quality is high on return ratios, supporting the ability to create value.
The PEG ratio is 0.95x, reflecting a relatively balanced link between valuation and growth.
The cash return period is stable at 21.2 days initially and 14.3 days at the end.
What the ratios show
Science Applications International Corporation combines solid capital returns with a discount to its own history. The main question is whether earnings and growth are sustainable.
Annual Financial Ratios Science Applications International Corporation
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.0 | 12.9 | 15.9 | 20.4 | 23.0 | 24.3 | 20.7 | 24.4 | 18.5 | 28.3 | 18.1 | 18.8 | 16.0 | - | - | - | |
P/S |
0.6 | 0.6 | 1.0 | 0.8 | 0.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 | 0.5 | 0.7 | 0.4 | - | - | - |
EPS |
7.7 | 7.2 | 9.0 | 5.4 | 4.8 | 3.6 | 3.9 | 3.2 | 4.1 | 3.2 | 2.5 | 3.0 | 2.3 | 3.7 | 3.7 | - |
EV (Enterprise Value) |
4.13 B | 4.61 B | 7.5 B | 6.06 B | 6.32 B | 4.88 B | 7.78 B | 6.18 B | 4.91 B | 5.52 B | 3.66 B | 3.39 B | 2.63 B | 3.28 B | 4.6 B | 4.21 B |
EBITDA per Share |
11.9 | 11.7 | 14.4 | 9.64 | 8.66 | 7.26 | 9.52 | 6.1 | 6.79 | 6.88 | 6.1 | 5.38 | 5.23 | - | - | - |
EV/EBITDA |
7.5 | 7.8 | 9.8 | 11.4 | 12.7 | 11.6 | 11.5 | 19.2 | 13.7 | 15.4 | 10.2 | 10.7 | 8.1 | - | - | - |
PEG |
0.95 | 1.7 | 0.71 | 1.93 | 2.87 | 3.6 | 0.84 | -1.07 | 0.64 | 1.08 | -1.2 | 0.76 | 0.35 | - | - | - |
P/B |
0.8 | 0.9 | 1.4 | 1.1 | 1.1 | 0.9 | 3.3 | 2.2 | 10.1 | 11.6 | 5.6 | 7.7 | 4.8 | - | - | - |
P/CF |
7.1 | 9.4 | 19.2 | 11.6 | 12.4 | 6.7 | 10.7 | 21.4 | 17.0 | 15.8 | 10.3 | 10.4 | 10.9 | - | - | - |
ROE % |
23.87 | 22.95 | 26.72 | 17.89 | 17.23 | 13.47 | 15.95 | 9.23 | 54.74 | 40.97 | 30.79 | 40.87 | 29.97 | - | - | - |
ROA % |
6.69 | 6.90 | 8.98 | 5.47 | 4.86 | 3.65 | 4.80 | 3.00 | 8.63 | 7.00 | 5.51 | 10.15 | 7.81 | - | - | - |
ROCE % |
34.73 | 35.70 | 41.51 | 29.57 | 28.54 | 25.13 | 11.67 | 6.00 | 18.58 | 18.53 | 15.83 | 28.67 | 27.29 | - | - | - |
Current Ratio |
- | - | - | - | - | - | 1.3 | 1.6 | 1.4 | 1.4 | 1.4 | 1.7 | 1.8 | - | - | - |
DSO |
46.6 | 46.7 | 45.4 | 46.2 | 48.8 | 53.3 | 62.9 | 82.3 | 55.2 | 44.3 | 53.7 | 51.1 | 55.0 | - | - | - |
DIO |
- | 0.1 | 2.1 | 3.6 | 4.0 | 4.7 | 5.4 | - | - | - | - | - | 5.7 | - | - | - |
DPO |
32.3 | 33.2 | 33.1 | 33.1 | 31.5 | 30.4 | 33.9 | 39.6 | 35.9 | 30.0 | 32.8 | 32.4 | 37.0 | - | - | - |
Operating Cycle |
46.6 | 46.8 | 47.4 | 49.8 | 52.8 | 58.0 | 68.3 | 82.3 | 55.2 | 44.3 | 53.7 | 51.1 | 60.7 | - | - | - |
Cash Conversion Cycle |
14.3 | 13.6 | 14.3 | 16.7 | 21.2 | 27.6 | 34.4 | 42.7 | 19.3 | 14.3 | 20.9 | 18.7 | 23.7 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Science Applications International Corporation
| 2027-Q2 | 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
2.72 | 2.63 | - | 1.7 | 2.72 | 1.43 | - | 2.15 | 2.72 | 1.43 | - | 2.15 | 1.59 | 1.49 | - | 1.79 | 4.6 | 1.8 | - | 1.45 | 1.31 | 1.3 | - | 1.24 | 1.42 | 1.39 | 1.02 | 1.03 | 0.88 | 0.62 | -0.2 | 0.95 | 0.97 | 0.93 | 1.19 | 1.13 | 1.15 | 1.16 | 0.79 | 0.99 | 0.83 | 1.12 | 0.61 | 0.93 | 0.8 | 0.69 | 0.78 | 0.74 | 0.48 | 0.72 | 0.68 | 0.8 | 0.72 | 0.71 | 0.88 | 0.45 | 0.51 | 0.69 | - | 0.92 | 0.78 | 1.16 | - | - | - | - |
EBITDA per Share |
3.6 | 5.01 | - | 5.16 | 4.5 | 3.3 | - | 5.34 | 3.1 | 3.3 | - | 3.36 | 2.73 | 3.22 | - | 2.82 | 7.31 | 3.55 | - | 2.95 | 2.82 | 2.96 | - | 4.12 | 3.66 | 2.96 | 1.52 | 4.14 | 3.15 | 1.92 | 0.12 | 3.41 | 2.82 | 2.12 | 1.44 | 2.49 | 1.74 | 1.82 | 1.34 | 1.67 | 1.86 | 1.67 | 1.2 | 2.56 | 2.15 | 1.78 | 1.28 | 2.3 | 1.65 | 1.35 | 1.14 | 1.7 | 1.45 | 1.33 | - | 0.97 | 0.86 | 1.13 | - | 1.69 | 1.47 | - | - | - | - | - |
ROE % |
29.67 | 26.13 | 18.05 | 24.62 | 27.84 | 23.98 | 19.47 | 26.04 | 24.45 | 20.46 | 15.94 | 21.03 | 27.85 | 28.66 | 24.28 | 29.00 | 28.33 | 19.35 | 13.56 | 17.87 | 18.19 | 18.91 | 14.49 | 18.72 | 18.41 | 16.92 | 14.37 | 9.53 | 9.51 | 10.22 | 11.40 | 27.60 | 35.29 | 44.39 | 55.70 | 50.14 | 51.81 | 49.54 | 49.04 | 46.38 | 44.51 | 43.35 | 37.24 | 40.31 | 37.50 | 33.31 | 33.88 | 32.20 | 34.41 | 38.02 | 38.07 | 36.53 | 32.21 | 26.86 | 23.84 | 6.57 | 3.99 | - | - | - | 6.07 | - | - | - | - | - |
ROA % |
8.41 | 7.34 | 5.19 | 7.19 | 8.20 | 7.06 | 5.76 | 7.77 | 7.22 | 6.42 | 5.12 | 9.47 | 7.47 | 9.11 | 7.64 | 9.07 | 8.71 | 5.63 | 3.99 | 5.19 | 5.16 | 5.26 | 3.98 | 5.26 | 5.08 | 4.55 | 3.75 | 2.28 | 2.43 | 2.80 | 3.40 | 6.06 | 7.07 | 8.21 | 9.40 | 8.65 | 8.52 | 7.92 | 7.93 | 7.54 | 7.43 | 7.39 | 6.45 | 7.72 | 7.35 | 6.63 | 7.53 | 7.22 | 8.27 | 9.63 | 9.71 | 10.89 | 9.79 | 9.42 | 3.45 | 1.52 | 2.01 | - | - | - | - | - | - | - | - | - |
ROCE % |
39.02 | 38.25 | 25.67 | 35.59 | 36.29 | 35.17 | 27.13 | 37.05 | 35.37 | 33.66 | 25.62 | 33.44 | 43.16 | 44.19 | 36.74 | 44.59 | 44.32 | 32.26 | 22.98 | 29.91 | 30.24 | 30.92 | 23.34 | 29.55 | 29.96 | 28.75 | 26.10 | 20.36 | 19.83 | 19.97 | 20.74 | 39.23 | 50.18 | 63.25 | 77.19 | 75.14 | 79.74 | 77.73 | 76.17 | 73.47 | 71.28 | 71.86 | 70.60 | 73.49 | 69.65 | 64.46 | 62.59 | 60.34 | 62.54 | 65.21 | 65.37 | 60.75 | 53.26 | 43.12 | 37.24 | 11.04 | 6.06 | - | - | - | 9.90 | - | - | - | - | - |
DSO |
46.8 | 47.0 | - | 48.8 | 50.5 | 46.7 | - | 45.6 | 50.5 | 48.8 | - | 23.6 | 23.4 | 45.6 | - | 47.4 | 50.0 | 43.4 | - | 50.1 | 53.3 | 47.2 | - | 52.2 | 51.9 | 51.5 | 63.7 | 52.3 | 54.4 | 55.0 | 83.0 | 60.2 | 59.3 | 48.4 | 58.2 | 57.3 | 56.6 | 47.0 | 56.0 | 54.0 | 51.7 | 50.3 | 53.3 | 52.1 | 56.4 | 46.6 | 58.4 | 53.8 | 50.9 | 53.5 | 60.6 | 57.6 | 59.6 | 60.5 | 56.8 | 66.1 | 31.3 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.6 | - | - | - | 2.0 | - | - | - | 2.3 | - | - | - | 2.1 | - | - | - | 2.2 | - | - | - | 3.0 | - | - | - | 3.1 | - | - | - | 2.8 | - | - | - | 2.9 | - | - | - | 4.8 | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 17.4 | - | - | - | 15.5 | - | - | - | - | - | - | - | - | - | - | - | 15.6 | - | - | - | 13.3 | - | - | - | 14.5 | - | - | - | 13.2 | - | - | - | 12.6 | - | - | - | 14.0 | - | - | - | 15.9 | - | - | - | 13.1 | - | - | - | 16.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | 50.5 | 48.8 | - | 45.2 | - | 45.6 | - | 47.4 | 50.0 | 43.4 | - | 50.1 | 53.3 | 49.2 | - | 52.2 | 51.9 | 53.9 | 63.7 | 52.3 | 54.4 | 57.2 | 83.0 | 60.2 | 59.3 | 50.5 | 58.2 | 57.3 | 56.6 | 50.0 | 56.0 | 54.0 | 51.7 | 53.4 | 53.3 | 52.1 | 56.4 | 49.4 | 58.4 | 53.8 | 50.9 | 56.4 | 60.6 | 57.6 | 59.6 | 65.3 | 56.8 | 66.1 | 31.3 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | 50.5 | 48.8 | - | 45.2 | - | 45.6 | - | 47.4 | 50.0 | 43.4 | - | 50.1 | 53.3 | 35.9 | - | 52.2 | 51.9 | 39.4 | 63.7 | 52.3 | 54.4 | 44.0 | 83.0 | 60.2 | 59.3 | 37.9 | 58.2 | 57.3 | 56.6 | 36.0 | 56.0 | 54.0 | 51.7 | 37.5 | 53.3 | 52.1 | 56.4 | 36.3 | 58.4 | 53.8 | 50.9 | 39.7 | 60.6 | 57.6 | 59.6 | 65.3 | 56.8 | 66.1 | 31.3 | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Science Applications International Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Information technology industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Broadridge Financial Solutions
BR
|
$ 192.75 | -0.11 % | $ 22.4 B |  USA |
 |
Affirm Holdings
AFRM
|
$ 67.88 | 2.93 % | $ 22.8 B | USA |
 |
CDW Corporation
CDW
|
$ 173.16 | 2.24 % | $ 22.7 B | USA |
 |
Fiserv
FISV
|
$ 63.9 | 0.91 % | $ 35 B | USA |
 |
Gartner
IT
|
$ 193.15 | 2.24 % | $ 14.6 B | USA |
 |
Jack Henry & Associates
JKHY
|
$ 175.81 | 0.35 % | $ 12.6 B | USA |
 |
Computer Task Group, Incorporated
CTG
|
- | - | $ 152 M | USA |
 |
Leidos Holdings
LDOS
|
$ 133.95 | -2.4 % | $ 17.1 B | USA |
 |
Cognizant Technology Solutions Corporation
CTSH
|
$ 64.6 | -0.62 % | $ 31.5 B | USA |
 |
Priority Technology Holdings
PRTH
|
$ 7.9 | -0.06 % | $ 630 M | USA |
 |
Fidelity National Information Services
FIS
|
$ 30.1 | 6.4 % | $ 15.6 B | USA |
 |
Sabre Corporation
SABR
|
$ 1.84 | 3.67 % | $ 721 M | USA |
 |
Teradata Corporation
TDC
|
$ 33.38 | 1.83 % | $ 3.15 B | USA |
 |
GDS Holdings Limited
GDS
|
$ 22.63 | 5.7 % | $ 34.4 B |  China |
 |
Telos Corporation
TLS
|
$ 7.67 | -1.63 % | $ 559 M | USA |
 |
Unisys Corporation
UIS
|
$ 2.91 | -0.51 % | $ 207 M | USA |
 |
Usio
USIO
|
$ 2.19 | -24.74 % | $ 59 M | USA |
 |
LiveRamp Holdings
RAMP
|
$ 38.5 | 0.71 % | $ 2.47 B | USA |
 |
WidePoint Corporation
WYY
|
$ 6.11 | 0.16 % | $ 60.4 M | USA |
 |
Xerox Holdings Corporation
XRX
|
$ 1.05 | -2.34 % | $ 133 M | USA |
 |
Switch
SWCH
|
- | - | $ 8.39 B | USA |
 |
Perficient
PRFT
|
- | - | $ 2.58 B | USA |
 |
Infosys Limited
INFY
|
$ 12.31 | -2.22 % | $ 51 B |  India |
 |
CynergisTek
CTEK
|
- | -0.4 % | $ 16.4 M | USA |
 |
SYNNEX Corporation
SNX
|
$ 241.31 | 3.81 % | $ 19.8 B | USA |
 |
American Virtual Cloud Technologies
AVCT
|
- | -11.01 % | $ 19.5 M | USA |
 |
Accenture PLC
ACN
|
$ 253.94 | -1.77 % | $ 158 B |  Irlanda |
 |
EPAM Systems
EPAM
|
$ 164.35 | 0.13 % | $ 9.19 B | USA |
 |
Digimarc Corporation
DMRC
|
$ 7.66 | -4.13 % | $ 166 M | USA |
 |
Crexendo
CXDO
|
$ 5.06 | 0.5 % | $ 150 M | USA |
 |
CLPS Incorporation
CLPS
|
$ 0.87 | 4.82 % | $ 25.6 M | China |
 |
C3.ai
AI
|
$ 12.16 | 2.83 % | $ 1.57 B | USA |
 |
CSP
CSPI
|
$ 7.29 | 6.89 % | $ 67.8 M | USA |
 |
Chindata Group Holdings Limited
CD
|
$ 5.13 | -1.16 % | $ 3.74 B | China |
 |
Concentrix Corporation
CNXC
|
$ 32.79 | 2.6 % | $ 2.07 B | USA |
 |
ExlService Holdings
EXLS
|
$ 43.9 | -0.9 % | $ 7.07 B | USA |
 |
CGI
GIB
|
$ 81.06 | -1.76 % | $ 18.5 B |  Canada |
 |
CoreLogic, Inc.
CLGX
|
- | 0.59 % | $ 5.89 B | USA |
 |
CACI International Inc
CACI
|
$ 646.7 | -0.13 % | $ 14.3 B | USA |
 |
Genpact Limited
G
|
$ 43.46 | 0.91 % | $ 7.56 B |  Bermuda |
 |
Innodata
INOD
|
$ 38.13 | 8.79 % | $ 1.21 B | USA |
 |
The Hackett Group
HCKT
|
$ 13.42 | 0.15 % | $ 366 M | USA |
 |
DXC Technology Company
DXC
|
$ 15.28 | -0.26 % | $ 2.67 B | USA |
 |
Conduent Incorporated
CNDT
|
$ 1.35 | -1.36 % | $ 214 M | USA |
|
Research Solutions
RSSS
|
$ 1.93 | 6.63 % | $ 61.4 M | USA |
 |
Alithya Group
ALYA
|
- | 3.2 % | $ 105 M | Canada |
 |
Sykes Enterprises, Incorporated
SYKE
|
- | - | $ 2.15 B | USA |
 |
China Customer Relations Centers, Inc.
CCRC
|
- | 0.31 % | $ 119 M | China |
 |
Perspecta Inc.
PRSP
|
- | - | $ 4.73 B | USA |